| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tracon Pharmaceuticals, Inc. | Director | Director Stock Option (Right to Buy) | 18,000 | 19 Apr 2023 | Direct | ||
| ACHIEVE LIFE SCIENCES, INC. | Director | Stock Option (right to buy) | 4,400 | 31 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123025285-mattingly-martin-a-2023-04-19 | Tracon Pharmaceuticals, Inc. | 19 Apr 2023 | 1 | $0 | 4 | Director | 21 Apr 2023, 20:44 |
| /report/000120919122037675-mattingly-martin-a-2022-06-14 | Tracon Pharmaceuticals, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 16 Jun 2022, 21:23 |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | 31 May 2022 | 1 | $0 | 4 | Director | 01 Jun 2022, 16:08 |
| /report/000120919121043142-mattingly-martin-a-2021-06-10 | Tracon Pharmaceuticals, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 24 Jun 2021, 19:01 |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | 11 May 2021 | 1 | $0 | 4 | Director | 13 May 2021, 16:22 |